Caruso International

Delivering safe, accurate, and clinically meaningful diagnostic solutions

Every IVD product we develop begins with a clinical question and ends with a measurable impact on patient care. Our development process is built around scientific rigor, regulatory discipline, and the practitioners who rely on these solutions every day – ensuring reliability, compliance, and an exceptional user experience at every step.

We don’t just build the solution – we bring your team along for the journey. At every stage, we share our thinking, transfer knowledge, and build your team’s capability alongside our own. The goal isn’t dependency; it’s confidence.

1. Ideation  –  Identifying Clinical Needs & Opportunities

We start by listening. Our teams work directly with clinicians, laboratory professionals, and scientific experts to surface the diagnostic gaps that matter most. Each idea is evaluated on clinical value, technical feasibility, regulatory pathway, and commercial potential – ensuring we invest where we can make the greatest difference.

2. Planning  —  Translating Ideas Into a Clear Product Strategy

A strong concept deserves a disciplined plan. We define the product’s intended use, target users, and regulatory classification early – so that FDA, IVDR, and global market requirements shape the roadmap from day one, not as an afterthought. Risk assessments, specifications, and team alignment happen here, before a single line of code is written or a reagent is formulated.

3. Development  – Building and Optimizing the Diagnostic Solution

Cross-functional teams develop the assay, hardware, software, and consumables in parallel. We iterate rapidly – using analytical studies and early prototypes to refine performance, usability, and manufacturability. Every decision is data-driven, design-controlled, and fully documented. Speed and compliance are not in tension here; they reinforce each other.

4. Qualification  –  Validating Safety, Performance & Reliability

No product reaches the market without passing our most demanding scrutiny. Qualification encompasses:

• Analytical validation – sensitivity, specificity, precision, and robustness across edge cases
• Usability and human factors – evaluation with real end-users in realistic workflows
• Verification testing – across instruments, reagent lots, and operational environments
• Quality and safety review – comprehensive risk management and regulatory audit readiness

5. Launch  – Delivering a Ready-for-Market Diagnostic Solution

Launch is not a finish line – it’s a handoff to the people who depend on this product. We prepare labeling, instructions for use, training materials, and support documentation with the same care we apply to the science. Manufacturing readiness, quality release, and distribution are coordinated so the product arrives right. Post-market surveillance begins from day one.

6. Growth  – Scaling Adoption & Continuous Improvement

Real-world use is our most valuable data source. We monitor clinical feedback, performance trends, and market signals continuously – feeding that intelligence back into the product. Improvements to assay performance, expanded indications, workflow optimizations, and automation capabilities all emerge from ongoing partnerships with the laboratories and clinicians we serve.

7. Product Retirement  –  Managing End-of-Life Responsibly

When technology advances, guidelines shift, or a better solution emerges, we manage transitions with the same discipline we apply at launch. Structured retirement plans include transparent customer communication, transition support, and continued fulfillment of all regulatory obligations – because our commitment to the people using our products doesn’t end when a product does.

“We don’t build diagnostics to check a regulatory box. We build them because accurate answers save time, reduce harm, and give clinicians the confidence to act. This process exists to protect that purpose at every step.”